| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.500 | None | 0.928 | 1 | 0 | 1995 | 2020 | ||||||||
|
cathepsin D | 0.478 | 0.846 | 9.2E-04 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.900 | strong | 0.948 | 5 | 24 | 1996 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.400 | None | 0.875 | 3 | 0 | 1996 | 2019 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
disease | 0.400 | None | 0.943 | 3 | 0 | 1996 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.970 | 2 | 0 | 1996 | 2019 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 1996 | 2014 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.400 | None | 0.891 | 1 | 0 | 1996 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.947 | 4 | 0 | 1997 | 2020 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.700 | limited | 0.903 | 4 | 2 | 1997 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1997 | 2020 | ||||||||
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.582 | 0.500 | 7.2E-08 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
promyelocytic leukemia | 0.477 | 0.846 | 0.21 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.974 | 5 | 0 | 1998 | 2019 | ||||||||
|
N-acetyltransferase 2 | 0.451 | 0.885 | 3.3E-06 |
|
disease | 0.400 | None | 0.882 | 4 | 0 | 1998 | 2017 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.887 | 3 | 0 | 1998 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.970 | 3 | 0 | 1998 | 2020 | ||||||||
|
kallikrein related peptidase 2 | 0.653 | 0.423 | 1.3E-04 |
|
disease | 0.400 | None | 0.970 | 2 | 0 | 1998 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.979 | 2 | 0 | 1998 | 2020 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.400 | None | 0.976 | 2 | 0 | 1998 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.400 | None | 0.931 | 2 | 0 | 1998 | 2019 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 1998 | 2009 | ||||||||
|
parathyroid hormone like hormone | 0.453 | 0.846 | 0.81 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2014 |